
Number of publications published per year by Dimou, Evangelini. (Source : PubMed)

Distribution of publications types for Dimou, Evangelini. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)


Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.
Hepatology
2007;45;2

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
Hepatology
2006;44;3

Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin.
Am. J. Clin. Oncol.
2005;28;6
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.
Hepatology
2005;42;1

Therapeutic administration of pegfilgrastim instead of prophylactic use.
Anticancer Res.
2005;25;3c
[ See timeline ] [ See all publications ]
means that Dimou, Evangelini has 7 papers cited a least 7 times - methodology
Hepatitis Research Laboratory, Athens University School of Medicine, and Henry Dunant Hospital, Athens, Greece.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.